[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase
![[Featured Stock] Daebong LS Soars 21.83% on Announcement of Free Capital Increase](http://www.asiae.co.kr/news/img_view.htm?img=2022071210592646439_1657591166.jpg)
[Asia Economy Reporter Hwang Junho] Daebong LS is surging on news of a free capital increase by its subsidiary, P&K Skin Clinical Research Center.
As of 10:14 AM on the 12th, Daebong LS is trading at 8,790 KRW, up 16.27% from the previous day.
On the same morning, P&K Skin Clinical Research Center announced a decision to issue three free shares for every one common share. Trading of this stock was suspended for 30 minutes from the time of the announcement due to the disclosure of major matters.
Hot Picks Today
"One Less Worry About Old Age": Japanese Companies Secure Senior Talent with Regular Employment Beyond 65
- "Shares Soar 600% on Debut as Retail Investors Flock to 'Robot Company'"
- Pilots and Cabin Crew Rank First and Second in Radiation-Related Cancer Deaths... The Reason Is 'Cosmic Radiation'
- "Six in Ten Koreans Support Female Conscription, Survey Finds"
- Raising Prices Boosts Sales... Revival of China's 'Doomed' Ramen Market
Daebong LS is the largest shareholder, holding 54.74% of P&K Skin Clinical Research Center's shares.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
